➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Medtronic
AstraZeneca
Johnson and Johnson
Baxter

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Entacapone - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for entacapone and what is the scope of freedom to operate?

Entacapone is the generic ingredient in two branded drugs marketed by Orion Pharma, Ajanta Pharma Ltd, Aurobindo Pharma Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Sun Pharm, Sunshine Lake, and Wockhardt Ltd, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for entacapone. Sixteen suppliers are listed for this compound.

Drug Prices for entacapone

See drug prices for entacapone

Recent Clinical Trials for entacapone

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Xiangya Hospital of Central South UniversityEarly Phase 1
Bial - Portela C S.A.Phase 4
TFS Trial Form SupportPhase 1

See all entacapone clinical trials

Pharmacology for entacapone
Paragraph IV (Patent) Challenges for ENTACAPONE
Tradename Dosage Ingredient NDA Submissiondate
COMTAN TABLET;ORAL entacapone 020796 2007-04-11

US Patents and Regulatory Information for entacapone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm ENTACAPONE entacapone TABLET;ORAL 090690-001 Jul 16, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Wockhardt Ltd ENTACAPONE entacapone TABLET;ORAL 078941-001 Aug 16, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for entacapone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999   Start Trial   Start Trial
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999   Start Trial   Start Trial
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Express Scripts
Boehringer Ingelheim
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.